Podcasts about Atomic

Today on your Wednesday Drive with Milly and Rosetta: What's Up with The Labour Party's Keiran McAnulty, Rosetta chats with REI and Play It Strange CEO Stephanie Brown about a new Play It Strange Podcast - On The Record with REI, and the duo catch up with RadioActive for Parakuihi Pals! Thanks to Atomic!

Today on your Wednesday Drive with Milly and Rosetta: What's Up with The Labour Party's Keiran McAnulty, Rosetta chats with REI and Play It Strange CEO Stephanie Brown about a new Play It Strange Podcast - On The Record with REI, and the duo catch up with RadioActive for Parakuihi Pals! Thanks to Atomic!

Send us a textIn this episode of Late to Grid, we sit down with Dexter Shreeve, who shares the story of finally chasing down his motorsports dream—starting with a Track Night in America event…in his daily driver Toyota Camry.Dexter walks us through the nerves, the excitement, and the learning curve of getting on track for the first time. From buying his first helmet on the way to the event to pushing his Camry harder than ever before, Dexter's story proves that you don't need a race car to get started—you just need to go.We also talk about vintage racing dreams, balancing family and business ownership with track time, and how even the smallest first step can lead to big things.Whether you're still “thinking about it” or reminiscing about your first event, Dexter's story will inspire you to stop waiting and just drive.Race season is here. If you need to catch up on setup, or have something that needs repaired, you need to be Atomic prepped. Get to https://atomicautosports.com/ to get your car ready to get out there next weekend. If you're chasing lap times, you need a track ready setup for your car. Get to AtomicAutosports.com to get your car scheduled to get you on the podium. Track ready setups for time trial drivers and others Thanks for listening and taking an interest in growing grassroots racing. The Late To Grid podcast shares the stories and inspiration that help listeners along their motorsports journey. Find all episodes on the Atomic Autosports website.

Today on Tuesday Breakfast with Milly and Rosetta: Isthmus'n That with Deputy Mayor Desley Simpson, Babe Martin is in the studio for a chat about her new single 'Sundog', and Cheng-Huan Lu talks about his thesis for Ready Steady Learn. Plus Short Player thanks to Hunter and NZOA, and news, weather and surf! Whakarongo mai nei! Thanks to Atomic!

Efter ett framgångsrikt 70-tal kände sig George Clinton utmanövererad av branschen, föll ner i ett crackberoende och drog sig tillbaka till sin farm. Lyssna på alla avsnitt i Sveriges Radio Play. Var Pfunken över? När alla tittade bort kom svaret genom ett nummer som förändrade hans liv igen.Det var en snöig dag i Detroit. En hög George Clinton med farhågor om att han hade förlorat sin förmåga att skapa hits halkade på trapporna till studion. Väl i sångbåset gick han loss över det klinkande ljudet från metallobjekt och ett märkvärdigt baklängesbeat. Skällde och agerade galet, lite mer än vanligt. ”Atomic dog” sände chockvågor genom hiphopkulturen och sköt elektronisk funk i en ny riktning. Bara Ice Cube har samplat låten sju gånger. Dr. Funkenstein lyckades kliva ut ur ett kraschat rymdskepp, men nya utmaningar låg framför honom.Programserien bygger på sju möten med George Clinton, samt i detta avsnitt även intervjuer medbland andra Gary Shider, Shirley Hayden, Malia Franklin (Parlet), Fred Wesley, Maceo Parker, Afrika Bambaataa, Amp Fiddler, Kevin Goines, Mitch McDowell General Kane), Patti Labelle, Nona Hendryx, En Vogue och Snoop Dogg.

It's Monday Brekkie with Milly and Rosetta! Today on the show, the pair chat with electronic duo M3SHES about their new track 'Sell Me', Oto interviews Manchester rapper Aitch, and Jenna is up in studio for Loose Reads. Whakarongo mai nei! Thanks to Atomic!

Gold , I tell ya Gold. Take a sheet.

Today: As the nation quietly observes Atomic Veterans Day this week, one Sierra Vista resident reflects on a once-classified mission, decades of silence, and a legacy that’s only now coming to light. Read more: https://www.myheraldreview.com/news/sierravista/unsung-heroes-air-force-retiree-didnt-know-atomic-vet/article_c8d9c715-877d-4ff8-9038-f4e7809e04af.html Support the show: https://www.myheraldreview.com/site/forms/subscription_services/See omnystudio.com/listener for privacy information.

It's Friday Brekkie with Milly and Rosetta! On today's show we chat about 'Music from Portland, Oregon' with Dr. Kirsten Zemke, for Travelling Tunes, Litia chats to us about Lena Dunham's new show 'too much' for Viewmaster, and Cam from Southbound Records comes up for From the Crate, to chat new records on the shelves for this weekend. Many great tunes, many great chats! Thanks to Atomic!

It's 95bFM Breakfast with Milly and Rosetta! On todays show, the pair catch up with David Slack and ask 'what if there'd been no Covid-19 vaccine?' for Political Commentary - and Georgia Knight phones in to have a kōrero about her new single 'Desire'! Whakarongo mai nei! Thanks to Atomic!

It's 95bFM Breakfast with Milly and Rosetta! On todays show, the pair catch up with David Slack and ask 'what if there'd been no Covid-19 vaccine?' for Political Commentary - and Georgia Knight phones in to have a kōrero about her new single 'Desire'! Whakarongo mai nei! Thanks to Atomic!

Welcome back to 95bFM Breakfast with Milly and Rosetta! Today on the show, IMNZ Chairperson Pippa Ryan-Kidd has a kōrero with Rosetta about Going Global, and Outrageous Fortune co-writer James Griffin is up for a chat about the show's 20th anniversary! Whakarongo mai nei! Thanks to Atomic!

This week Justin reconnects with Dr. Frank Close. Frank is Professor Emeritus of Theoretical Physics and Fellow Emeritus at Exeter College at the University of Oxford. He was formerly the head of the Theoretical Physics Division at the Ruthford Appleton Laboratory Vice President of the British Science Association and Head of Communications and Public Understanding at CERN. He is a fellow of the Royal Society and won their Michael Faraday Medal for Excellence in Science Communication in 2013. He received the Order of the British Empire for services to research and the public understanding of science in 2000. You may remember Frank from episode 195, when he joined the show to unveil the life of atomic scientist Bruno Pontecorvo.Frank is back today to discuss his newest book, Destroyer of Worlds: The Deep History of the Nuclear Age, which is available now. It's a complete history of atomic research and its weaponization plus the spies who work to steal this research for the benefit of their own governments.Check out Frank's first appearance on episode 195: 'Nuclear Physicist or Soviet Spy? The Enigma of Bruno Pontecorvo' here.Connect with Frank:Twitter/X: @CloseFrankCheck out the book, Destroyer of Worlds, here.https://a.co/d/f8XcXDNConnect with Spycraft 101:Get Justin's latest book, Murder, Intrigue, and Conspiracy: Stories from the Cold War and Beyond, here.spycraft101.comIG: @spycraft101Shop: shop.spycraft101.comPatreon: Spycraft 101Find Justin's first book, Spyshots: Volume One, here.Check out Justin's second book, Covert Arms, here.Download the free eBook, The Clandestine Operative's Sidearm of Choice, here.FAMILY HISTORY DRAMA : Unbelievable True StoriesWhether it's great lives or great tragedies, or just showing up for the adventure,...Listen on: Apple Podcasts SpotifyHistory by MailWho knew? Not me! Learn something new every month. Use code JUSTIN10 for 10% off your subscription.Disclaimer: This post contains affiliate links. If you make a purchase, I may receive a commission at no extra cost to you.Support the show

It's bFM Breakfast with Milly and Rosetta! Today on the show, the pair chat with Alphabethead about his epic new track 'I'm Lucy Lawless' and signing to Sun Return, and Dr Sereana Naepi is on the show for Ready Steady Learn, to chat about her work on the newly published book 'Oceans Between Us: Pacific Peoples and Racism in Aotearoa'. Plus, Short Player with The Circling Sun thanks to Hunter and NZOA, news, weather, surf, and plenty of tunes! Whakarongo mai nei! Thanks to Atomic! 

It's Milly and Rosetta's second Breakfast! Today on the show, the duo chat with Alphabethead about their new track 'I'm Lucy Lawless', and catch up with Dr Sereana Naepi for Ready Steady Learn. Whakarongo mai nei! Thanks to Atomic!

Chris fled a declarative-first world for the promised land of Bluefin's atomic simplicity. Fifty days in, did he find desktop bliss or just fresh compromises?Sponsored By:1Password Extended Access Management: 1Password Extended Access Management is a device trust solution for companies with Okta, and they ensure that if a device isn't trusted and secure, it can't log into your cloud apps. Unraid: A powerful, easy operating system for servers and storage. Maximize your hardware with unmatched flexibility. Support LINUX UnpluggedLinks:

We can use the force of habit to produce the action of faith – so that our simple daily routines lead us into God's presence. From July 13, 2025

Kids & Family and Education - Lightcircle Entertainment

Pastor Chris continues our series in Atomic (be)Attitudes. This week he teaches on Powelessness.

It's Rosetta and Milly's first show as 95bFM Breakfast co-hosts! They're super excited, and had an awesome first show - complete with Fashun with Penelope Noir, and Loose Reads with Suri! Thanks to Atomic! 

"Blondie" grubunun 1979 çıkışlı "Eat to the Beat" albümünde yer alan ve 16 Temmuz 1945'teki "Trinity testi"yle başlayan nükleer çağın etkilerini barındıran punk-rock türündeki şarkının hikâyesi.

Dr. Hash Hashemian has been an inspiring leader in the nuclear industry for half a century. He was recently inaugurated as the President of the American Nuclear Society (ANS) after serving for a year as the Vice President/President Elect. His company, AMS Corporation, provides key services and products to nearly every nuclear power plant in...

SHOW SCHEDULE 7-9-25. Good evening. The show begins in Ukraine still waiting for air defense supply... 1856 BLACK SEA FLEET CBS EYE ON THE WORLD WITH JOHN BATCHELOR FIRST HOUR 9:00-9:15 #Ukraine: Air power cannot win a war. Colonel Jeff McCausland, USA (Retired) @mccauslj @cbsnews @dickinsoncol 9:15-9:30 #Ukraine: NATO prepares Rotterdam. Colonel Jeff McCausland, USA (Retired) @mccauslj @cbsnews @dickinsoncol 9:30-9:45 Harvard: What is to be done? Peter Berkowitz, Hoover. 9:45-10:00 Harvard: What is to be done? Peter Berkowitz, Hoover continued. SECOND HOUR 10:00-10:15 Atomic bomb education. Peter Huessy, @gordongchang, Gatestone, Newsweek, The Hill 10:15-10:30 LEO: Weaponizing lasers vs Germany EU. Rick Fisher, @gordongchang, Gatestone, Newsweek, The Hill 10:30-10:45 PRC: Rumors of Xi. Charles Burton, @gordongchang, Gatestone, Newsweek, The Hill 10:45-11:00 PRC: Weaponizing LEO. Brandon Weichert, @gordongchang, Gatestone, Newsweek, The Hill THIRD HOUR 11:00-11:15 Solomons vs PRC. Cleo Paskal, FDD 11:15-11:30 Solomons vs PRC. Cleo Paskal, FDD continued 11:30-11:45 End of Russiagate. @andrewcmccarthy @nro @thadmccotter @theamgreatness 11:45-12:00 Russia asset seizures. Michael Bernstam FOURTH HOUR 12:00-12:15 France: Wildfires at Marseilles. Simon Constable 12:15-12:30 England: Bayeux comes to the UK. Simon Constable 12:30-12:45 ULA: Is the Vulcan ready? Bob Zimmerman behindtheblack.com 12:45-1:00 AM Mars: Meteorite for sale. Bob Zimmerman behindtheblack.com Key corrections made:

“Butter and C*nty Smock.” In this episode, your hosts Martyr (@dragthemartyr) and Cate (@ctepper) catch up about Pride, Broadway, drag shows, Fire Island and The Tony's. Then they discuss ISLYNYC's brand new store opening in Brooklyn, and “Brokeback Mountain.” Later, returning guest Atomic Annie stops by! She tells us about graduating college, walking NYFW, meeting Theresa Caputo, “The Substance,” and the hot wings “Mx Chicken Pageant.” Plus games galore! + Follow our guest: @_atomicannie on all social media + Catch up with the first time Atomic Annie came to the show: https://pod.link/1460638348/episode/e8eb6f4bbc3c87a15432bcd05a065304 ~ tinyurl.com/wiggingoutpodcast This episode is proudly sponsored by MOTTO- the new queer dating app! Tired of the endless scrolling? With Motto, Motto sends you daily matches of people who match your interests and kinks. There are no fees, no ads, and no nonsense. Use invite code: ZVOGS when signing up. ~ Follow the pod on Instagram and Facebook @wiggingoutpodcast and on twitter @wiggingoutpod Thots, comments, and dick pics? Please send to dragthemartyr@gmail.com Cover art: Madeline De Michele - www.madelinedemichele.com Music: “Club” by Andrew Huang (www.youtube.com/channel/UCdcemy56JtVTrsFIOoqvV8g) under Creative Commons. Edits by C.Tepper

PREVIEW ATOMIC WEAPONS: Colleague Peter Huessy comments that the Chinese public is deceived by the CCP about the peril of atomic bombs. More. 1940

What s My File Name Malware may use the GetModuleFileName API to detect if it was renamed to a name typical for analysis, like sample.exe or malware.exe https://isc.sans.edu/diary/What%27s%20My%20%28File%29Name%3F/32084 Atomic macOS infostealer adds backdoor for persistent attacks Malware analyst discovered a new version of the Atomic macOS info-stealer (also known as 'AMOS') that comes with a backdoor, to attackers persistent access to compromised systems. https://moonlock.com/amos-backdoor-persistent-access HOUKEN SEEKING A PATH BY LIVING ON THE EDGE WITH ZERO-DAYS At the beginning of September 2024, an attacker repeatedly exploited vulnerabilities CVE-2024- 8190, CVE-2024-8963, and CVE-2024-9380 vulnerabilities to remotely execute arbitrary code on vulnerable Ivanti Cloud Service Appliance devices. https://www.cert.ssi.gouv.fr/uploads/CERTFR-2025-CTI-009.pdf SEO Scams Targeting Putty, WinSCP, and AI Tools Paid Google ads are advertising trojaned versions of popuplar tools like ssh and winscp https://arcticwolf.com/resources/blog-uk/malvertising-campaign-delivers-oyster-broomstick-backdoor-via-seo-poisoning-and-trojanized-tools/

For this episode - Kelby Watt joins the show! He is the driver of the #1K 410 winged sprint car out of Adel, Iowa.Discussed:Sending it out of the park at Cedar Lake SpeedwaySeason stats. Snagging a win in Wisconsin and making the trip to the Terre Haute Action Track with POWRi on a Sunday. Being a small team and managing all the irons in the fire. Phone calls and ending up in the Bill Rose #6!Importance of traveling College and getting a brief gig for NASCAR.Bucket list? Moving to Pennsylvania? Throwback schemesWho not to mess with on/off the track

In this episode of The Girl Dad Show, host Young Han sits down with Healey Cypher, CEO of BoomPop and Partner/COO at Atomic. Healey has spent his career building and selling companies centered around remarkable customer experiences—from selling Oak Labs to Zivelo, to leading Zivelo as CEO and exiting to Verifone, to his early days driving innovation at eBay. But beyond the boardroom, Healey is also a devoted dad of two, a husband, and someone who strives daily to be a good human. Healey shares why travel, gratitude, and hiring great people are key to building a fulfilling life and a lasting business. This is a must-watch for any parent-entrepreneur looking to lead with heart and build something meaningful—at home and at work. ✨ All episodes of The Girl Dad Show are proudly sponsored by Thesis, helping founders go further, together. Takeaways: The transition from virtual to in-person events post-pandemic How AI is changing the game in event planning The influence of childhood in Saudi Arabia on Healey's global outlook Balancing high-growth entrepreneurship with being a present parent How values like integrity and empathy show up in leadership Breaking generational patterns and embracing personal growth Thanks for watching!

Blue Wave AI Labs has been creating and supplying artificial intelligence tools – mainly in the form of machine learning – to operating nuclear power plants since 2016. Their initial set of tools focused on improving boiling water reactor core reload designs. The company was formed to address the chosen problem because it was a...

Aaron Maté : MI6 and Atomic Weapons InspectionsSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

AST SpaceMobile has closed a $100 million equipment financing facility led by Trinity Capital Inc. Atomic-6 has won a $2 million Tactical Funding Increase (TACFI) from US Space Force Space Systems Command to mature and flight qualify their solar array for commercial and defense sectors. Alén Space has been selected to manufacture the next five satellites for Sateliot, and more. Remember to leave us a 5-star rating and review in your favorite podcast app. Be sure to follow T-Minus on LinkedIn and Instagram. T-Minus Guest Our guest today is Abigail Glover, Astronaut Scholar 2024 - 2025. You can connect with Abigail on LinkedIn, and learn more about the Astronaut Scholarship Foundation on their website. Selected Reading AST SpaceMobile Secures Additional $100.0 Million of Liquidity from Non-Dilutive Equipment Financing Atomic-6 Wins $2M Space Force Contract for Revolutionary Solar Array Technology Sateliot advances its constellation with 5 new satellites manufactured by Alén Space NASA Awards Simulation and Advanced Software Services II Contract Watch Russia's Progress 92 cargo ship launch toward the ISS today- Space Is Oman's proximity to equator the secret to its growing space launch potential?- Times of India Boeing taps veteran insider Parker to lead its defense and space unit- Reuters Rockies, York Space Systems announce jersey patch partnership   Juventus Lunar Outpost Prematch Jersey T-Minus Crew Survey Complete our annual audience survey before August 31. Want to hear your company in the show? You too can reach the most influential leaders and operators in the industry. Here's our media kit. Contact us at space@n2k.com to request more info. Want to join us for an interview? Please send your pitch to space-editor@n2k.com and include your name, affiliation, and topic proposal. T-Minus is a production of N2K Networks, your source for strategic workforce intelligence. © N2K Networks, Inc. Learn more about your ad choices. Visit megaphone.fm/adchoices

AI Software, Web and Mobile Apps, Product Design and more! Discover what Michigan company has been custom building software for 200+ Organizations since 2001.In this episode we welcome Jonah Bailey, Managing Partner at Atomic Object, as he talks about the future of AI and software technology. Atomic Object is a software development and design consultancy that customizes programs for each unique client. With offices from Ann Arbor to Grand Rapids, Chicago and North Carolina, they are developing in industries including health tech, real estate, agriculture, sports and more. 

JaySin and the Horror King are back with some wild news! Jay has another exclusive on Chasyn Rance and his pal Booker T. Plus, an update on the Human Dateline special, known as TNA employee and Wrestling Atomic co-owner Alex Red. Aka Alejandro who is about to testify for a trafficker! https://wrestlevoice.com/2025/07/01/meltzer-sapp-rso-booker-t-busted/  

On May 19, 1945, eleven days after the surrender of Nazi Germany in Europe, a U-boat was escorted into Portsmouth Naval Yard, New Hampshire. News reporters covering the surrender of U-234 were ordered, contrary to all previous and later U-boat surrender procedures, to keep their distance from crew members and passengers of U-234, on threat of being shot by the attending Marine guards. Why the tight security? Buried in the nose of the specially-built mammoth boat, sealed in cylinders “lined with gold,” was 1,120 pounds of enriched uranium labeled “U235”the fissile material from which atom bombs are made. Critical Mass documents how these Nazi bomb components were then used by the Manhattan Project to complete both the uranium bomb dropped on Hiroshima and the plutonium bomb dropped on Nagasaki, to defeat the Japanese and win World War Two and global domination in the modern age.https://amzn.to/3TVIyhnBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-opperman-report--1198501/support.

NUKES: THE PATH TO ATOMIC WEAPONS IS ATOMIC POWER. HENRY SOKOLSKI, NPEC 1957 VA

Rocket Lab successfully launches 67th Electron Mission, schedules next launch in less than 48 hours. US NSF and Amazon's Project Kuiper establish coordination agreement to prevent satellite interference. Sidus Space picks Atomic-6 for solar arrays in $120M cislunar data mission with Lonestar. And, more. Remember to leave us a 5-star rating and review in your favorite podcast app. Be sure to follow T-Minus on LinkedIn and Instagram. T-Minus Guest We are joined by NASASpaceflight.com with the Space Traffic Report. Selected Reading Rocket Lab Successfully Launches 67th Electron Mission, Schedules Next Launch in Less Than 48 Hours (Rocket Lab) Project Kuiper and U.S. National Science Foundation sign satellite coordination agreement (Amazon) Sidus Space Advances $120M Agreement with Lonestar, Selects Atomic-6 as Solar Array Partner for Cislunar Data Satellite Mission (Sidus Space) SpaceX says debris recovery attempts hindered after Starship explosion (Reuters) SpaceX Polluted Border Area, Mexican President Sheinbaum Says (Bloomberg) China's Shenzhou-20 astronauts complete second EVA (CGTN)  Scientists Are Sending Cannabis Seeds to Space (WIRED) T-Minus Crew Survey Complete our annual audience survey before August 31. Want to hear your company in the show? You too can reach the most influential leaders and operators in the industry. Here's our media kit. Contact us at space@n2k.com to request more info. Want to join us for an interview? Please send your pitch to space-editor@n2k.com and include your name, affiliation, and topic proposal. T-Minus is a production of N2K Networks, your source for strategic workforce intelligence. © N2K Networks, Inc. Learn more about your ad choices. Visit megaphone.fm/adchoices

PREVIEW: Colleague Henry Sokolski of NPEC comments that atomic weapons are the willful product of any country acquiring nuclear power reactors. More.

इस हफ़्ते पुलियाबाज़ी पर और एक सफ़रनामा। इस बार चलिए करते हैं जापान की सैर। ३.५ करोड़ की आबादी वाला शहर टोक्यो कैसे चलता है? एटॉमिक बम से धराशयी होने वाला शहर हिरोशिमा आज कैसा दीखता है? जापान के अद्यतन पब्लिक ट्रांसपोर्ट से भारत क्या सीख सकता है?We discuss:* Public Transport in Japan* Innovation in public transport funding* Land readjustment for urban development* Pedestrian friendly cities* Meiji restoration* Hiroshima and the effects of Atomic bomb* Japanese Toilets* Cultural aspects of Japan* Japanese aestheticsAlso, please note that Puliyabaazi is now available on Youtube with video.Read:Article | How to redraw a cityBook | Japan Story by Christopher HardingListen:Kimi Wo Nosete (Carrying You) | Joe Hisaishi | Chorus version with subtitlesKimi Wo Nosete (Carrying You) | OST sung by Azumi InoueKanashikute Yarikirenai - In This Corner of the World OSTOmoide - Tsunekichi Suzuki Lyrics and translation (Tokyo Diner OST)Joe Hisaishi - One Summer's DayRelated episodes:सफ़रनामा: अमरीका से थाईलैंड से केन्या तक। Travelogue from US, Thailand, Kenyaसफ़रनामा: रोबोटिक्स का तीर्थस्थल। Boston TravelogueIf you have any questions for the guest or feedback for us, please comment here or write to us at puliyabaazi@gmail.com. If you like our work, please subscribe and share this Puliyabaazi with your friends, family and colleagues.Website: https://puliyabaazi.inHosts: @saurabhchandra @pranaykotas @thescribblebeeTwitter: @puliyabaaziInstagram: https://www.instagram.com/puliyabaazi/Subscribe & listen to the podcast on iTunes, Google Podcasts, Castbox, AudioBoom, YouTube, Spotify or any other podcast app. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.puliyabaazi.in

  Jim recently attended a mini JFK conference in San Francisco with notables like Peter Dale Scott, Bill Simpich, etc.. Jim spoke about JFK and his policies regarding the Middle East at the well exclusive JFK mini conference. What is currently happening in the Middle East is very relevant. JFK assassination research continues to be VERY relevant. Jim feels Nasser has been the most influential Arab leader in the Middle East during the 20th century, perhaps ever. Nasser was not an Islamic fundamentalist, he was a Socialist. Nasser was not a monarchist he was a Pan-Arabist. Saudi Arabia did not like Nasser. Nasser believed all of the oil in the Middle East belonged to all of the Arabs. Nasser wanted funds from the oil bearing nations to create highways, schools, hospitals & development of the Middle East. Nasser felt that all of the countries in the middle east should be in a confederation, protecting their joint interests. Saudi Arabia was a monarchist country and Islamic state, inevitably the royalist families would come to blows with Nasser. For a short time Syria was united with Egypt, known as the United Arab Republic. There was a war of succession in 1963 in Yemen that Nasser got involved in. Followers of Nasser in Yemen faced off with the royalist family. Saudi Arabia backed the royalist family to weaken Nasser. Israel very much feared Nasser, believing he was the one Arab leader who could unify the Middle East against Israel. Israel tried twice to destabilize Nasser, in 1954 with the Lavon Affair & in 1956 with the Suez crisis. The Muslim Brotherhood, Islamic troops for Saudi Arabia tried to assassinate Nasser twice, once in 1954 and 1965. A perceptive Kennedy saw Nasser as opposition to the medieval Saudi Arabia and a balancing point to Israel. When questioned about he feelings regarding JFK, Sirhan expressed deep respect, as JFK was standing up for Palestine. Sirhan loved JFK. He admired that JFK was putting pressure on Israel to let the Palestinian people to return to their homes. JFK promised Arab leaders he would do his best to make Israel comply with the 1948 United Nations resolution. All of JFK's efforts for peace in the Middle East ended with his assassination. The 1948 UN resolution has been ignored. How did JFK's influence in the Middle East effect the Arab people? What were JFK's goals? JFK and Nasser started a long letter writing campaign to each other that lasted until JFK was murdered. Gamal Abdel Nasser, 2nd President of Egypt, died unexpectedly Sept 28, 1970 at only 52 years of age. Kennedy had felt that John Foster Dulles had made a big mistake turning on Nasser and supporting Saudi Arabia. When Kennedy was murdered, Nasser couldn't sleep Nasser ordered JFK's funeral to be aired 3 times as he fell into a depression. Did Nasser understand that JFK's assassination was the beginning of the end? When Nasser died, 6 million people poured into Cairo to watch Nasser's funeral. Watch Video Here 46 people were killed and 80 injured in the stampede of people. RFK wanted the American Zionist Council to register as an Foreign lobby. Nicholas Kazenbach, after JFK's death & RFK resigned, ended enforcement against the AZC. Now look where we're at. Johnson gave the AZC tax break backdated back to 1956. This became the creation of AIPAC. The conflict in the Middle East and Israel was Atomic weapons. Atomic weapons is the cause of the current situation with Iran!  

Standard Nuclear emerged from the start-up stealth mode in early June 2025 with the announcement of successfully raising $42 million from a group of venture capitalist led by  Decisive Point with participation from Andreessen Horowitz, Washington Harbour Partners, Welara, Fundomo and Crucible Capital. Though Standard Nuclear is young enough to have a single page web site, it owns and operates the largest...

News of a ceasefire in the Israel-Iran-US conflict was met with cheers from much of the MAGA movement, who believed they could finally engage in their own ceasefire of firing off justifications for the lack peace. It was announced as a “https://www.npr.org/2025/06/23/g-s1-74059/iran-attack-us-bases-iraq-qatar?fbclid=IwY2xjawLHXKlleHRuA2FlbQIxMQBicmlkETF3QjhuM05yVkphM28yeTJyAR5sL4ve-8fBM78ziM5d_aTxQd56LsgInEnwwEiTyLI43mkOh7raQUPima3yOg_aem_Qg4v6KvGaBWCKif4los39A” though the President wrote that “there will be a Complete and Total CEASEFIRE.” But the United States cannot lie about a fake feud with Israel, lie to Iran about peace negotiations, assist the Israelis in assassinating the top peace diplomat, and lie to the American public about not being involved and not getting involved, and then proceed to bomb that country directly and demand peace, while threatening https://www.newsweek.com/donald-trump-considering-tactical-nukes-against-iran-what-we-know-2088461. In other words, claiming that you got peace in a war you started and lied about is a masterclass in gaslighting and deception Then, to further claim to claim that a staggered ceasefire is an absolute cease-fire, when a staggered cease-fire is informal, and not an armistice ceasefire. Peace or not, this is an important little detail, because multiple cease-fires that Trump worked out between Israel and what we call Hamas have been broken by Israel. The same types of cease-fires were broken under the Biden ministration as well by Israel. So it's possible they are lying about a ceasefire so when Iran continues firing missiles they become the aggressor and magically…regime change, which Trump https://www.msn.com/en-us/news/world/trump-says-iran-may-need-regime-change/ar-AA1He2Nybefore the supposed deal.As https://www.spreaker.com/episode/a-place-called-armageddon-6-17-25--66585678: Just as Mariam Adelson called Trump the “savior of the Jewish people,” it appears he will be both the deceiver and the bringer of peace on the world stage. They will create peace from the chaos and once again break it as part of the art of tribulation.” And in a https://x.com/TST___Radio/status/1937467453866672594 16 post: If “peace” comes about through war then Trump, who green lit the operation, will be painted as the savior of Israel just like Adelson predicted. It would be a double ruse; lying to Iran, bombing them, then stepping in to grant fake peace. They are creating Biblical prophecy to strip Muslims and Christians of their faith.”It all fits in to the manufactured prophecy about peace, and the belief that Mariam Adelson, who gave Trump $100 million, has that Trump is the “savior” of the Jewish people.MAGA does not get to be this absolutely wrong, and then still claim to be the party of peace and America. You cannot start a war, deny that it is a war, then claim you ended a war you started with a fake ceasefire and fake peace. Particularly because even if we could all agree on why Iran cannot have a nuclear weapon, the reasoning for the attack was based on a computer algorithm, not actual intelligence. And regardless of this logical assessment, the US bombing of Iran didn't work, or were possibly staged! From Gaza to Ukraine to Iran, https://militarycognizance.com/the-ai-that-triggered-a-war-how-palantir-and-the-iaea-fueled-israels-strike-on-iran/ from Palantir, has been reportedly at the center of it all. And now, if Iran did not have a weapon before, they certainly could have one now, with https://www.newsweek.com/russia-says-countries-now-ready-supply-iran-nuclear-weapons-2088979. It's probably no coincidence then that the https://fortune.com/2024/08/17/palantir-alex-karp-us-3-front-war-russia-china-iran-autonomous-weapons-drones-military-draft/ there would be a 3-front war against Russia, China, and Iran, or that https://finance.yahoo.com/news/palantir-pltr-lands-1-3b-213719986.html for war on top of their half a billion last year https://archive.md/SP4ll#selection-1579.51-1579.56 that assists in identifying military points of interest. It's probably no coincidence that the https://www.forbes.com/sites/antoniopequenoiv/2024/07/16/jd-vance-and-peter-thiel-what-to-know-about-the-relationship-between-trumps-vp-pick-and-the-billionaire/, Peter Thiel, or that the company's https://www.npr.org/2025/05/01/nx-s1-5372776/palantir-tech-contracts-trump, or that Trump just appointed technocratic computer geeks as Lt Cols. In the military - from https://www.army.mil/article-amp/286317/army_launches_detachment_201_executive_innovation_corps_to_drive_tech_transformation. This is also while an actual Pentagon Colonel, Nathan McCormack, the https://www.thejc.com/news/usa/us-israel-planner-sacked-death-cult-cz8o38kk, was just fired for calling Israel a “death cut.” It's probably no coincidence that virtual all of this is run by Israel zealots, Jewish supremacists, and Christian zionists, from Palantir to OpenAI (Sam Altman), Oracle (Larry Ellison), Nvidia (Chris Malachowsky), and https://www.nbcnews.com/news/world/black-cube-inside-shadowy-israeli-firm-accused-trying-undermine-iran-n877511.Something feels off about the whole thing, more than what is obvious. It almost feels like more than a production, maybe something akin to a simulation with real world consequence. It feels like an invisible war, with Iran acting as nothing but a location for the simulation. It all just feels like a movie, be it WarGames, Wag the Dog, or the television show Fallout where a group of business managers plan the end of the world and to guarantee their investments in vaults - like the https://www.independent.co.uk/news/world/americas/underground-city-secret-bunker-bush-official-b2745199.html actually has - by deciding to drop the bomb themselves when peace talks between waring countries become more solid. When JD Vance said this could be an “https://www.realclearpolitics.com/video/2025/06/23/vp_vance_the_12_day_war_was_an_important_reset_moment_for_the_entire_region.html,” not only is that game talk, but it's also WEF pandemic talk. So was Trump's statement about a https://www.npr.org/2025/06/20/nx-s1-5440143/trump-two-weeks-deadline-pattern for a decision on Iran. Some people are even attempting to contact their relatives in Iran and hearing robotic voices that the AP reported on stating, “Five experts with whom the AP shared recordings said it could be low-tech artificial intelligence, a chatbot or a pre-recorded message to which calls from abroad were diverted.” Almost as if contact has been cut off from Iran or that maybe there was never contact to begin with, like an invisible war is being waged like the one we waged on an invisible virus. Even Thomas Massie said the bombings of Iran were the 2025 version of “https://x.com/RepThomasMassie/status/1936899611362243064.”Everything that is happening, from electric cars and cryptocurrency, to mass surveillance, to the great reset of Trump' golden age, is all part of the same NWO conspiracy system. And furthermore, whatever MAGA stood for has been traded for false goods, a demonic bargain that results in the loss of one's soul for illusion. And if the plan is not followed by the POTUS, Vance, the Palantir puppet, will be installed. *The is the FREE archive, which includes advertisements. If you want an ad-free experience, you can subscribe below underneath the show description.-https://www.spreaker.com/podcast/tst-radio--5328407https://thesecretteachings.info/donate-subscribe/https://x.com/TST___Radio https://www.facebook.com/thesecretteachingshttps://www.youtube.com/@TSTRadioOfficialhttp://tstradio.infohttps://cash.app/$rdgable: $rdgable Paypal email rdgable1991@gmail.comEMAIL: rdgable@yahoo.com / TSTRadio@protonmail.comBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-secret-teachings--5328407/support.

Dr. Shaalan Beg and Dr. Kristen Ciombor discuss practice-changing studies in GI cancers and other novel treatment approaches that were presented at the 2025 ASCO Annual Meeting. Transcript Dr. Shaalan Beg: Hello, I'm Dr. Shaalan Beg, welcoming you to the ASCO Daily News Podcast. I'm a medical oncologist and an adjunct associate professor at UT Southwestern Medical Center in Dallas, Texas. There were some remarkable advances in gastrointestinal cancers that were presented at the 2025 ASCO Annual Meeting, and I'm delighted to be joined by Dr. Kristen Ciombor to discuss some exciting GI data. Dr. Ciombor is the Ingram Associate Professor of Cancer Research and a co-leader of Translational Research and the Interventional Oncology Research Program at the Vanderbilt Ingram Cancer Center. Our full disclosures are available in the transcript of this episode. Dr. Ciombor, it's great to have you on the podcast today. Dr. Kristen Ciombor: Thanks, Dr Beg. It's great to be here. Dr. Shaalan Beg: Alright, let's kick it off. Big year for GI cancers. We'll start off with LBA1. This was the ATOMIC study sponsored by NCI and the National Clinical Trials Network (NCTN) and the Alliance group. This is a randomized study of standard chemotherapy alone or combined with atezolizumab as adjuvant therapy for stage III mismatch repair deficient colorectal cancer. Dr. Kristen Ciombor: I think this study was really definitely practice-changing, as you can tell because it was a Plenary. But I do have some concerns in terms of how we're actually going to implement this and whether this is the final answer in this disease subtype. So, as you said, the patients were enrolled with stage III resected mismatch repair deficient colon cancer, and then they were randomized to either modified FOLFOX6 with or without atezolizumab. And that's where it starts to become interesting because not many of us give FOLFOX for 6 months like was done in this study. Obviously, the study was done over many years, so that was part of that answer, but also the patients received atezolizumab for a total of 12 months. So the question, I think, that comes from this abstract is, is this practical and is this the final answer? I do think that this is practice-changing, and I will be talking to my patients with resected mismatch repair deficient colon cancer about FOLFOX plus atezolizumab. I think the big question is, do these patients need chemotherapy? And can we do a neoadjuvant approach instead? And that's where we don't have all the answers yet. Dr. Shaalan Beg: Yeah, but it has been great to see immunotherapy make its way into the adjuvant space after having made such a big impact in the metastatic space, but still some unanswered questions in terms of the need for chemotherapy and then the duration of therapy, which I guess we'll have to stay tuned in for the next couple of years to to get a lot of those questions answered. Dr. Kristen Ciombor: Yeah, but a big congratulations to the study team, to the NCTN, the NCI. I mean, this is really a great example of federally funded research that needs to continue. So, great job by the study team. The DFS 10% difference is really very large and certainly a practice-changing study. Dr. Shaalan Beg: Yeah, and and sticking with colon cancer, and and this another federally funded study, but this time funded by a Canadian cancer clinical trials group was LBA3510. This is the CHALLENGE study. It's a randomized phase 3 trial of the impact of a structured exercise program on disease-free survival for stage III or high-risk stage II colon cancer. This study got a lot of buzz, a lot of mainstream press coverage, and a lot of discussions on what that means for us for the patients who we're going to be seeing next week in our clinic. What was your takeaway? Dr. Kristen Ciombor: Yeah, this is a really interesting study, and I was so glad to see it presented because this partially answers one of the questions that patients always have for us in clinic, right? You know, once they've completed their standard chemotherapy and surgery, what else can they do to help prevent recurrence? And so we've always known and sort of extrapolated that healthy lifestyle habits are good, but now we have data, particularly in these patients. Most of them were stage III colon cancer patients, those had high-risk stage II cancer. And basically, the goal was to increase their physical activity by at least 10 MET hours per week. So, my big question, of course, as I came into this presentation was, “Okay, what does that mean exactly? How does that translate to real life?” And really what the author presented and explained was that basically most patients could hit their target by adding a 45- to 60-minute brisk walk 3 to 4 times a week. So I think this is very approachable.  Now, in the confines of the study, this was a structured exercise program, so it wasn't just patients doing this on their own. But I do think kind of extrapolating from that, that this is very achievable for most patients. And not only did this prevent recurrence of their prior cancer, but actually the rate of new primary cancer diagnoses, was less, which is really interesting, especially in the breast and prostate cancer. So this was a really interesting, and I think practice-changing study as well, especially given that this is something that most patients can do. Dr. Shaalan Beg: Yeah, and there was a lot of discussion in the hallways after the presentation in terms of how this really changes our existing practice because most folks already recommend exercise as a way for improving outcomes in cancer patients. So we've already been doing that. Now we have some data on how much it can impact the benefit. But there was some discussion about what the actual degree of impact was. There was a drop-off rate in terms of how long folks were able to stick with this exercise regimen. But you've seen this in clinic when someone have their surgery, they have their chemotherapy, they've been so intimately involved with the oncology world, with the oncology practice, and they somehow feel that they're being let loose into this mean, angry world without any guidance and they're looking for something to do. “What more can I do in terms of my lifestyle?” And then here we have very solid data, as solid as can be for an intervention like exercise, showing that there is an impact and you can give a prescription for exercise when someone wraps up their chemotherapy for colon cancer, thanks to the study. Dr. Kristen Ciombor: Yeah. It was a great study. Dr. Shaalan Beg: Moving to gastroesophageal cancer, another late-breaking abstract. This is LBA5. The MATTERHORN trial was a phase 3 trial of durvalumab plus FLOT for resectable GE junction and gastric cancer. And again, another area where immunotherapy has made an impact, and here we're seeing it move closer for earlier-stage disease. What was your take-home for the MATTERHORN trial? Dr. Kristen Ciombor: Yeah, so this study looked at neoadjuvant perioperative durvalumab plus our current standard chemotherapy of FLOT versus placebo plus FLOT. And this was a large study, almost 1,000 patients were randomized. And the primary endpoint was event-free survival, and it was definitely met in favor of the D + FLOT arm, as Dr. Klempner discussed after Dr Janjigian's presentation. I do think there are still some unanswered questions here. Overall survival is not yet mature, so we do have to wait and see how that shakes out. But it's very interesting and kind of is reflective of what, as you said, we're looking at earlier and earlier lines of therapy, particularly with immunotherapy, in these GI cancer spaces. So it makes a lot of sense to test this and and to look at this. So the toxicity was pretty similar to what we would expect. Primary endpoint was met, but again, we'll have to wait and see what the survival data looks like. Dr. Shaalan Beg: Yeah, and in oncology, we know, especially for treatment that does add additional cost, it does add additional potential toxicity that we want to see that overall survival nudged. I did see some polls on social media asking folks whether their practices changed from this, and I think the results were favoring adding durvalumab for this group of patients but understanding that there are caveats to the addition of treatments and the eventual FDA approval in that indication as well. Dr. Kristen Ciombor: Exactly. I completely agree with that. Dr. Shaalan Beg: All right. How about we stick with gastroesophageal cancer? LBA4002 was trastuzumab deruxtecan versus ramucirumab plus paclitaxel for second-line treatment in HER2-positive unresectable or metastatic gastric cancer or GE junction cancer. This was the DESTINY-Gastric04 study. And again, antibody-drug conjugates making a big impact across different diseases. And here we have more data in the HER2-positive gastric cancer space. Your thoughts on this study? Dr. Kristen Ciombor: Yeah, so this is a really important space in gastroesophageal cancer because the HER2 positivity rate is fairly high as compared to some of our other tumor types. So, I do think one of the important things was that patients did have biopsy confirmation of HER2 status, which was very important, and then they were randomized to either T-DXd versus the kind of second-line standard of ramucirumab-paclitaxel. So this was a great practical study and really answers a question that we had for a while in terms of does anti-HER2 therapy in the second-line really impact and improve survival. So we did see a statistically significant improvement favoring T-DXd. I do think it's always important to look at toxicity, though, too. And there was about almost 14% rate of interstitial lung disease, which of course is the most feared toxicity from some of these antibody-drug conjugates, especially T-DXd. So I do think it's important to keep that in mind, but this is definitely a great addition to the armamentarium for these HER2-positive patients. Dr. Shaalan Beg: And pancreas cancer was on the stage after a very long time with a positive clinical trial. This is Abstract 4006. These were preliminary results from a phase 2 study of elraglusib in combination with gemcitabine/nab-paclitaxel versus gemcitabine/nab-paclitaxel alone for previously untreated metastatic pancreas cancer. This is a frontline clinical trial of gemcitabine/nab-paclitaxel plus/minus the study drug. There were other cohorts in this study as well, but they reported the results of their part 3B arm. And great to see some activity in the pancreas space. And your thoughts? Dr. Kristen Ciombor: Yeah, we definitely need better treatments in pancreas cancer. This was a very welcome presentation to see. The elraglusib is an inhibitor of GSK-3beta, and it's thought that that mediates drug resistance and EMT. And so this is, I think, a perfect setting to test this drug. So patients basically were randomized. Patients with metastatic pancreas cancer were randomized 2: 1 to gemcitabine/nab-paclitaxel plus or minus this elraglusib. So, what we saw was that overall survival was better with the addition of this new drug. And overall, not only the 1-year overall survival, but also median overall survival.  The thing that was interesting, though, was that we saw that the overall survival rates were 9.3 months with the combination versus 7.2 months with just gemcitabine/nab-paclitaxel. And that's a little bit lower than we've seen in other studies. So, not sure what was going on there. Was it the patients that were a bit sicker? Was it a patient selection, you know, thing? I'm not really sure how to explain that so much. Also, the toxicity profile was much higher in terms of visual impairment, with over 60% of patients being treated with the combination versus 9% with gemcitabine/nab-paclitaxel. So these were mild, grade 1 and 2, but still something to be cautious about. Dr. Shaalan Beg: And especially with this being a phase 2 trial, making sure that in a larger study we're able to better evaluate the toxicity and see if the control arm in the larger confirmatory study performs differently will be really important before this compound makes it to the clinic in our space. But very exciting to see these kinds of results for pancreas adenocarcinoma. Dr. Kristen Ciombor: Yeah. Dr. Shaalan Beg: We've talked, it seems, a couple of times on this podcast about the BREAKWATER clinical trial. We did hear PFS and updated OS data, updated overall survival data on first-line encorafenib plus cetuximab plus modified FOLFOX6 for BRAF-mutated colorectal cancer. This was LBA3500. And eagerly anticipated results – we have all previously heard the progression-free survival results – but here we heard updated overall survival results, and very well-received study it seemed from the audience that time. So what are your takeaways on the updated results for BREAKWATER? Dr. Kristen Ciombor: In my opinion, this was one of the most practice-confirming studies. As you mentioned, we've already seen some of the preliminary data of BREAKWATER at prior meetings. But really what was particularly impactful for me was the median overall survival with the BREAKWATER regimen. So, again, patients received FOLFOX, encorafenib cetuximab in the first line if they had BRAF-mutated V600E-mutated colorectal cancer. And the median PFS was 12.8 months, which was actually really remarkable in this traditionally very aggressive, poor prognosis subtype of tumors. So, by seeing a median overall survival of 30.3 months was just incredible, in my opinion. Just a few years ago, that was considered the median overall survival for all comers for metastatic colorectal cancer. And we know the median overall survival was more in the less than 12 months range for BRAF. So this was incredibly impactful, and I think should be absolutely practice-changing for anyone who is eligible for this regimen.  I think again, where the practice meets the study is what's kind of important to think about too, how long did patients get FOLFOX, and certainly it adds toxicity to add a BRAF-targeted regimen on top of FOLFOX already. So, one of the other interesting things about the study, though, was that even though it didn't complete treatment, they actually did look at encorafenib/cetuximab alone and in the first line without chemotherapy. And those preliminary results actually looked okay, especially for patients who might not be able to tolerate chemotherapy, which we certainly see in practice. So, overall, definitely more data. And I agree that it's certainly practice-changing. Dr. Shaalan Beg: And it completely, as you mentioned, changes the outlook for a person who's diagnosed with BRAF-mutated metastatic colon cancer today versus even 7 or 8 years ago. Dr. Kristen Ciombor: And we're seeing this over and over in other subtypes too, but how you choose to treat the patient up front really matters. So really giving the right regimen up front is the key here. Dr. Shaalan Beg: And along the same lines, Abstract 3501 wanted to answer the question on whether people with MSI-high metastatic colorectal cancer need double checkpoint inhibitor therapy or is single therapy enough. So this [CheckMate-8HW] study compared nivo plus ipi with nivo alone, nivo monotherapy for MSI-high metastatic colorectal cancer. And we've known that both of these are fairly active regimens, but we also know the chance of immune-related adverse events is significantly higher with combination therapy. So this was a much-needed study for this group of patients. And what were your takeaways here? Dr. Kristen Ciombor: This, of course, has been really nivo-ipi in the first-line MSI-high metastatic colorectal cancer is now a standard of care. And not everybody is eligible for it, and there could be reasons, toxicity reasons, and other things too. But as we've been seeing for the last couple of years, immunotherapy clearly beats chemo in this space. And now looking at doublet versus single immunotherapy treatment in the first line, I think really nivo-ipi does beat out monotherapy. I will say, however, there is a caveat in that we still haven't seen the nivo-ipi versus nivo in the first line. So what has been presented thus far has been across all lines of therapy, and that does muddy the waters a little bit. So definitely looking forward and and we've asked this many times and based on the statistical plan and and what not, you know, we just haven't seen that data yet. But I do think it's becoming increasingly important to consider doublet immunotherapy for these patients as long as there are no contraindications. With the again, with the caveat that we have to have these toxicity discussions in the clinic with patients because many patients can tolerate it, you know, this regimen fairly well, but there can be very severe toxicities. So, I think an informed discussion should really be had with each patient before moving forward. Dr. Shaalan Beg: Yeah, informed decision, making them aware of the potential of real significant toxicities, immune-related toxicities with double therapy. But I am curious in your practice, how often do you see people choosing doublet therapy as frontline? Dr. Kristen Ciombor: So patients are really savvy, and a lot of times they've heard this data before or have come across it in patient advocacy groups and other things, and it's really nice to be able to have that conversation of the risk versus benefit. So I will say not all of my patients choose doublet, and many of them are still cured with immunotherapy monotherapy. So the big question there is, will we ever understand who actually needs the doublet versus who can still be cured or have very good long-term outcomes with just the single agent? And that has not been answered yet. Dr. Shaalan Beg: What a great point. So the last abstract I was hoping we could talk about is POD1UM-303 or the INTERAACT2 subgroup analysis and impact of delayed retifanlimab treatment for patients with squamous cell carcinoma of the anal canal. What were your thoughts here? Dr. Kristen Ciombor: This was a study, actually we saw at ESMO, we saw the primary data at ESMO last year, and this was an update with some exploratory analyses. But this was really an important study because once again, we're looking at immunotherapy in later lines of therapy. That's how we started looking at and investigating immunotherapy, and now we're moving it up and up in the treatment course. So this was a study of carboplatin/paclitaxel plus or minus retifanlimab. Actually it was retifanlimab versus placebo. And it was a positive study, as we heard last year. This actually led to FDA approval of this regimen last month, just before ASCO, and it has now been incorporated in the NCCN guidelines as the preferred first-line option.  So what I thought was important from the additional data presented at ASCO was looking at the different subgroups, it did not appear that patients with liver mets or not had different outcomes. So that was really good to see because sometimes in colon cancer we see that immunotherapy doesn't work as well when patients have liver mets. And interestingly, because we use immunotherapy in anal cancer without any biomarkers, unlike with colon cancer or some of the other tumor types, also the authors looked at PD-L1 status, and it did look like maybe patients did a little bit better if they had higher PD-L1 expression, but patients still could benefit even if they were PD-L1 negative. So that was important, I think, and we will continue to see further data come out from this study. I want to mention also that EA2176 just completed accrual, so that was carbo-taxol plus or minus nivolumab. And so we should be seeing that data sometime soon, which will hopefully also confirm the ongoing role for immunotherapy in the first-line setting for anal cancer. Dr. Shaalan Beg: That was a fantastic review. Thank you, Dr Ciombor. Thanks for sharing your valuable insights with us today on the ASCO Daily News Podcast. Dr. Kristen Ciombor: Thanks for having me here. Dr. Shaalan Beg: And thank you to our listeners for your time today. You will find links to the abstracts discussed today in the transcript of this episode. And if you value the insights that you hear on the podcast, please take a moment to rate, review, and subscribe, wherever you get your podcasts. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. More on today's speakers:   Dr. Shaalan Beg  @ShaalanBeg  Dr. Kristen Ciombor @KristenCiombor Follow ASCO on social media:    @ASCO on Twitter   @ASCO on BlueSky  ASCO on Facebook    ASCO on LinkedIn    Disclosures:   Dr. Shaalan Beg:   Consulting or Advisory Role: Ipsen, Cancer Commons, Foundation Medicine, Science37, Nant Health, Lindus Health Speakers' Bureau: Sirtex Research Funding (Inst.): Delfi Diagnostics, Universal Diagnostics, Freenome Dr. Kristen Ciombor: Consulting or Advisory Role: Pfizer, Incyte, Exelixis, Bayer, ALX Oncology, Tempus, Agenus, Taiho Oncology, Merck, BeiGene Research Funding (Inst.): Pfizer, Boston Biomedical, MedImmune, Onyx, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Merck, Novartis, Incyte, Amgen, Sanofi, Bristol-Myers Squibb, Array BioPharma, Incyte, Daiichi Sankyo, Nucana, Abbvie, Merck, Pfizer/Calthera, Genentech, Seagen, Syndax Travel, Accommodations, Expenses: Incyte, Tempus

Overcoming the Controller Saboteur & Mastering Problem-Solving as a Business OwnerIn this episode, we dive deep into the impact of the Controller saboteur on business owners and their teams. We discuss how a need for control can stifle growth, prevent effective delegation, and create unnecessary stress. We also explore how shifting from a controlling mindset to a curious and open approach can improve leadership and team dynamics. Additionally, we break down the importance of problem-solving in business and how the most successful entrepreneurs embrace challenges rather than avoid them.Key Takeaways:• Recognizing Your Saboteurs: Many business owners struggle with the Controller saboteur, which can hinder their ability to delegate, accept feedback, and foster collaboration.• The Antidote to the Controller Saboteur: Remaining curious and open to learning helps counteract the need for control and allows for better decision-making and team involvement.• The Impact on Others: Controlling tendencies don't just affect the individual but also impact employees, stifling their ability to contribute and collaborate effectively.• Breaking Through Comfort Zones: Business growth requires continuous evolution, stepping out of familiar roles, and embracing new challenges.• The Transition to Leadership: When business owners finally have an efficient team, they often struggle with their new role, sometimes self-sabotaging by creating unnecessary problems.• Managing Money Issues: Entrepreneurs often experience financial stress when they stop doing what initially made them successful. Staying focused on revenue-generating activities is crucial.• The Importance of Problem-Solving: Business is about solving problems. The best entrepreneurs develop systems to assess and address problems efficiently rather than getting overwhelmed.• Handling Business Transitions: Transitioning from one level of success to the next requires maintaining core business activities while also adapting and growing into new responsibilities.• Planning for Success: Business owners should anticipate potential challenges and create strategies to handle obstacles as they arise, rather than reacting in crisis mode.Actionable Steps:1. Assess Your Saboteurs: Identify if you have controlling tendencies and how they may be impacting your business.2. Practice Curiosity: Challenge yourself to seek feedback and remain open to learning from others.3. Empower Your Team: Allow employees to take ownership of their roles so you can focus on strategic growth.4. Stay Financially Disciplined: Don't create unnecessary expenses just because your business is growing—stay focused on generating revenue.5. Embrace the Problem-Solving Mindset: Shift your mindset from “problems are overwhelming” to “problems are opportunities.”6. Plan for Transitions: Make intentional plans for growth rather than assuming success will continue without change.Resources & Next Steps:• Learn more about identifying and overcoming your saboteurs at AtomicBusinessCoaching.com.• Check out the Simple CEO Program to help you step into your role as a business leader effectively.• Connect with us on social media for more business insights and coaching tips.Join the Conversation:What are your biggest struggles with delegation and control in your business? Share your thoughts with us and let's discuss strategies to help you grow.Tune in Next Week!Be sure to subscribe and join us next week as we continue diving into the mindset shifts and strategies that help business owners succeed!

The A-bomb had contributed to this soft reign of terror. It had also fired a period of excitement and fertility in the neglected field of science fiction. Before WWII, sci-fi in film was widespread, with examples such as Lang's hallmark Metropolis, Things To Come, the silent 20,000 Leagues Under The Sea, The Lost World, and serials populated by Flash Gordon and Buck Rogers. The war had shifted the focus, to combat and military films, propaganda, home-front boosterism, and escapism. The war also brought awareness of the application of science to conflict. Atomic power had brought an entirely new set of horrific sci-fi characters --- as embodied by Bela Lugosi, played by Martin Landau in the film Ed Wood: “Today it's all giant bugs. Giant spiders, giant grasshoppers...” Increasingly, sci-fi enemies came from the outside, from other worlds loosening tremendous power upon the Earth, or beings from our world mutated and terribly changed by atomic power. Or sometimes, both. Aliens of all types were lurking every week at the Bijou in the 1950s. The Day The Earth Stood Still. The Thing From Another World, The War Of The Worlds. Some of these films were silly, and as characterized by Lugosi/Landau --- giant bugs. Some became classics, despite their pedigree, as in the film Invasion Of The Body Snatchers. The 1956 offering had an unlikely path to greatness, but it's stood the test of time because of the themes that run through its bones.Website and blog: www.thosewonderfulpeople.comIG: @thosewonderfulpeopleTwitter: @FilmsInTheDark

It's Monday, June 16th, A.D. 2025. This is The Worldview in 5 Minutes heard on 140 radio stations and at www.TheWorldview.com.  I'm Adam McManus. (Adam@TheWorldview.com) By Adam McManus Pakistani Christian acquitted of blasphemy against Islam charge Last Thursday, a Pakistani judge acquitted a 28-year-old Christian named Farhan Masih of blasphemy against Islam and terrorism charges after the prosecution failed to prove its case against him, reports Morningstar News. Masih had developed a mental illness due to excessive use of synthetic drugs and was entrapped in the false accusation by the complainant. According to Open Doors, Pakistan is the eighth most difficult country worldwide in which to live for Christians. Dear God, we thank you for enabling Farhan Masih, this Pakistani Christian, to be acquitted. Amen. Israel attacks Iran over atomic weapon; Iran retaliates Israel launched blistering attacks on the heart of Iran's nuclear and military structure Friday, deploying warplanes and drones previously smuggled into the country to assault key facilities and kill top generals and scientists, reports the Associated Press. Israeli Prime Minister Benajmin Netanyahu explained. NETANYAHU: “Moments ago, Israel launched Operation Rising Lion, a targeted military operation to roll back the Iranian threat to Israel's very survival. This operation will continue for as many days as it takes to remove this threat. For decades, the tyrants of Tehran have brazenly, openly called for Israel's destruction. They backed up their genocidal rhetoric with a program to develop nuclear weapons. “In recent years, Iran has produced enough highly enriched uranium for nine atom bombs – nine!  In recent months, Iran has taken steps that it has never taken before, steps to weaponize this enriched uranium. If not stopped, Iran could produce a nuclear weapon in a very short time. It could be a year. It could be within a few months.” Iran retaliated by firing waves of ballistic missiles at Israel, where explosions flared in the skies over Jerusalem and Tel Aviv and shook the buildings below. The Israeli military urged civilians to head to shelter, as missiles damaged homes and killed two people. U.S. Senate considers defunding Planned Parenthood In the midst of the U.S. Senate's ongoing debate about the budget, they are determining whether to defund Planned Parenthood, as President Trump has requested, reports Liberty Counsel Action. The situation is fluid and can change at any moment because of the razor-thin margin of votes.  Only  two weeks remain to get the budget on President Trump's desk.  Whether or not your two U.S. Senators are Republicans or Democrats, please call them at 202-224-3121 – any time of the day or night -- and urge them to DEFUND Planned Parenthood. Democratic Minnesota Rep. killed and Minnesota Senator injured in targeted attack A Minnesota Democratic lawmaker and her husband were shot and killed in their home early Saturday by someone posing as a police officer and a second Democratic lawmaker and his wife were wounded in what some have described as  “targeted political violence,” reports the Associated Press. Former Democratic House Speaker Melissa Hortman and her spouse were killed in their Brooklyn Park home. The other lawmaker, Democratic State Senator John Hoffman, and his wife, were shot multiple times in Champlin, a suburb of Minneapolis. Bob Jacobson, Minnesota Commissioner of Public Safety, spoke at a press conference. JACOBSON: “This is a dark day today for Minnesota and for democracy, but we will not allow fear or violence to define who we are or how we move forward.” The gunman has been identified as Vance Luther Boelter, whom Democratic Minnesota Governor Tim Walz had previously appointed to the Governor's Workforce Development Council. Christian singer Michael Tait confesses homosexual conduct & drug abuse Last Tuesday, Michael Tait, the former lead singer of the Christian rock band Newsboys and a member of the Grammy-winning group DC Talk, publicly confessed to a history of "reckless and destructive behavior," including drug and alcohol abuse and unwanted sexual conduct involving men, reports The Christian Post. In a written statement on Instagram, the 59-year-old singer acknowledged that the reports  are “sadly, largely true." He wrote, "For some two decades, I used and abused cocaine, consumed far too much alcohol, and, at times, touched men in an unwanted sensual way. I am ashamed of my life choices and actions, and make no excuses for them. I will simply call it what God calls it — sin. “I was violating everything I was raised to believe by my God-fearing Dad and Mom, about walking with Jesus and was grieving the very God I loved and sang about for most of my life. By His grace, I can say that for the past six months, I have lived a singular life—one of utter brokenness and total dependence on a loving and merciful God." Tait's confession follows an in-depth investigative report published on June 3rd by The Roys Report documenting that three men accused him of sexual assault during separate incidents dating back to 2004. Tait quoted Psalm 51, King David's famous prayer of repentance: "Blot out my transgressions … create in me a new heart, O God." God-haters upset with 10 Commandments displayed in Arkansas schools A group of God-hating organizations has filed a lawsuit against a recently passed law in Arkansas that requires public schools to display the Ten Commandments on the wall in a 16-inch by 20-inch poster with a  font size that makes it easily readable, reports The Christian Post. Americans United for Separation of Church and State, the American Civil Liberties Union, and the Freedom From Religion Foundation filed a complaint on Wednesday on behalf of a religiously diverse group of parents. At issue is Act 573, a measure signed into law by Arkansas Governor Sarah Huckabee Sanders in April and is scheduled to take effect in August. The lawsuit argues that "Act 573 is not neutral with respect to religion." Republican State Senator Jim Dotson, one of the bill's primary sponsors, argued in March that the Decalogue displays were not unconstitutional. He said, "From the state to the federal level all throughout our history, it is an historical reference point or historical document that has basic things like you shall not kill, steal, commit adultery -- those basic foundations of life that are good for everybody to keep front of mind so that we are hopefully living good lives," reports KATV. After God revealed the Ten Commandments to Moses on Mt. Sinai, Exodus 20:20 records Moses telling the Jews, “Do not be afraid. God has come to test you, so that the fear of God will be with you to keep you from sinning.” Worldview listeners in South Dakota, Colorado, and Indiana share their hearts I invited Worldview listeners to share what they enjoy about the newscast in 2-6 sentences by email.  You can share your thoughts -- along with your full name, city and state -- and send it to adam@TheWorldview.com Jason Bollwerk in Rapid City, South Dakota wrote, “I am a homeschooled sophomore in high school, and I listen daily to The Worldview for school. My reason for listening is not only to hear what is happening in the world, but I love hearing about all the good things that God is doing out there. Most media outlets show the dark side of what's going on. But The Worldview really shows what God's doing. Tally ho and pip pip.” Cheryl Ball in Indianapolis, Indiana wrote, “I've been reading the transcript of your newscast every morning since the presidential debates last year. I don't watch the news or read other news. So, this is basically my news input and I'm thankful for it.” And Dennis and Alyssa Guse in Castle Rock, Colorado, said, “Thank you for the faithful work you and The Worldview in 5 Minutes team do for the glory of God!  We are blessed to hear relevant news stories and encouraging Scriptures every day.  Keep up the great work for the Kingdom!”  Dennis asked if I could lead an occasional short prayer for one of the news items. I  called him to say that that was a great idea and I would take him up on the suggestion. 17 Worldview listeners gave $6,821 to fund our annual budget And finally, toward our midpoint goal of $61,750 to fund half of The Worldview newscast's annual budget by this past weekend, 17  listeners stepped up to the plate by 1:00pm Central on Saturday. We were only 3 donors short of our 20-donor goal. Our thanks to Augustine in Auburn, California who gave $25 as well as Elisabeth in Waterloo, Ontario, Canada and Karen in Waterford, Wisconsin --  both of whom gave $50, and Daniel in Mayflower, Arkansas who pledged $8 per month for 12 months for a gift of $96. We're grateful to God for Leasa in Simpsonville, South Carolina, George in Edinburgh, Indiana, and Woody in Sparks, Nevada – each of whom gave $100 as well as Laura in Millstadt, Illinois and Kerry and Rosana in San Antonio, Texas – both of whom gave $200. And we were touched by the generosity of Derrick in Evans, Georgia who gave $250, Justin and Oliver in Grover Beach, California who pledged $25/month for 12 months for a gift of $300, Eric in Warren, Minnesota who also pledged $25 per month for 12 months for a gift of $300, Matt, Amanda, Elijah, Malachi, and Samuel in Greencastle, Indiana who gave $450, Shy in Ingalls, Indiana who pledged $50 per month for 12 months for a total gift of $600, Aaron in Fort Bragg, North Carolina who gave $1,000, Katie in Hutchinson, Kansas who gave $1,000, and Scooter in Naples, Florida who will match those last two $1,000 donations with another $2,000 gift of his own. Those 17 Worldview listeners gave a total of $6,821. Ready for our new grand total? Drum roll please.  (Drum roll sound effect) $38,892.20 (People clapping and cheering sound effect)   That means we fell $22,857.80 short of our $61,750 mid-point goal to stay on the air and fund our 6-member Worldview newscast team for another fiscal year. Toward this Friday, June 20th's goal of $92,625, we need to raise $53,732.80. Remember, if you are one of the 4 final people who give a one-time gift of $1,000, Scooter in Naples, Florida will match you with a corresponding $1,000 gift.  Now, if that happens today, Monday, June 16th we will have raised an additional $8,000. In order to raise the remaining amount, I need to find 38 Worldview listeners who will pledge $50/month for 12 months for a gift of $600. And another 76 listeners to pledge $25/month for 12 months for a gift of $300. Has God placed it on your heart to be one of the Christian patriots to fund this unparalleled newscast which unashamedly cites relevant Scripture, includes compelling soundbites, and practical action steps to speak out for Biblical principles? Please, we need your help right now!  Go to TheWorldview.com and click on Give on the top right.   Click on the button that indicates a recurring monthly donation if that's your wish. I'll be honest. In my flesh, I'm getting very nervous indeed!  But, in my spirit, I confidently trust that God will prompt the right people to give generously to cover our annual budget. Close And that's The Worldview on this Monday, June 16th, in the year of our Lord 2025. Follow us on X or subscribe for free by Spotify, Amazon Music, or by iTunes or email to our unique Christian newscast at www.TheWorldview.com.  You can get the Generations app through Google Play or The App Store. I'm Adam McManus (Adam@TheWorldview.com). Seize the day for Jesus Christ.

In this episode of Quah (Q & A), Sal, Adam & Justin coach three Pump Heads via Zoom. Mind Pump Fit Tip: The 5 reasons why lifting weights is ALL you need. (1:38) The ultimate fat-burning/healing peptide stack. (25:41) Atomic energy. (33:28) The father-in-law funny trend. (36:06) Another reason to keep your kid off social media. (37:06) Celebrating Doug's 60th birthday. (39:55) Beef tallow is the jam! (45:07) Faith and happiness. (47:24) Chat GPT car repair. (54:34) #ListenerLive question #1 – Do you have suggestions or alternate exercises you can recommend to people with knee issues for MAPS 15? What would your recommendation be on how to proceed after knee surgery? (59:59) #ListenerLive question #2 – Should we generally get a few reps from failure with every set, or what is the target? (1:16:08) #ListenerLive question #3 – What is your opinion on the NASM certification for a teenager interested in becoming a personal trainer? (1:21:32) Related Links/Products Mentioned Ask a question to Mind Pump, live! Email: live@mindpumpmedia.com Visit Transcend for this month's exclusive Mind Pump offer! ** Telehealth Provider • Physician Directed GET YOUR PERSONALIZED TREATMENT PLAN!  Hormone Replacement Therapy, Cognitive Function, Sleep & Fatigue, Athletic Performance and MORE! ** Visit Paleovalley for an exclusive offer for Mind Pump listeners! ** Discount is now automatically applied at checkout: 15% off your first order! ** June Special: Shredded Summer Bundle or Bikini Bundle 50% off! ** Code JUNE50 at checkout ** Mind Pump # 1835: Why Resistance Training Is the Best Form of Exercise for Fat Loss and Overall Health Mind Pump # 1547: The Hidden Benefits of Lifting Weights Goodnight Call Trend: A Fun Way to Connect with Family - TikTok Morgan Hill Wine Trolley Visit Joy Mode for an exclusive offer for Mind Pump listeners! ** Enter MINDPUMP at checkout for 20% off your first order. ** MP Holistic Health Mind Pump # 1612: Everything You Need to Know About Sets, Reps & Rest Periods Personal Trainer Growth Secrets | Powered by MindPump – Facebook Trainer Bonus Series Episode 1: The Successful Trainer Mindset Trainer Bonus Series Episode 2: Diet & Exercise Strategies That Work AND Clients Love Trainer Bonus Series Episode 3: Assessments That Sell Training Mind Pump Podcast – YouTube Mind Pump Free Resources People Mentioned Jordan Syatt (@syattfitness) Instagram Jon Call (@jujimufu) Instagram Jay Campbell (@jaycampbell333) Instagram Arthur Brooks (@arthurcbrooks)  Instagram Jordan B. Peterson (@JordanBPeterson) X/Twitter Dr. Stephen Cabral (@stephencabral) Instagram  

* A Natural Selection: Fred Williams and Doug McBurney are joined on the air by author and researcher Tom Rogers, president of the Atomic Biology Institute to discuss his latest efforts to replace Darwinism with the Biblical and historical truth of how we are made and cared for by a super intelligent and loving God. * Honesty from Harvard: Harvard evolutionist Richard Lewontin admitted: "Our willingness to accept scientific claims that are against common sense is the key to an understanding of the real struggle between science and the supernatural. We take the side of science in spite of the patent absurdity of some of its constructs...in spite of the tolerance of the scientific community for unsubstantiated just-so stories, because we have a prior commitment, a commitment to materialism."  Anti-God and Anti-science. “in the last chapter of Biology as Ideology, Lewontin argued that "while traditional Darwin has portrayed the organism as a passive recipient of environmental influences, a correct understanding should emphasize the organism as an active constructor of its own environment." * Rom 1:25: “Who changed the truth of God into a lie, and worshipped and served the creature more than the Creator, who is blessed for ever. Amen. * Theistic Evolution: A Scientific, Philosophical and Theological Critique – Get the book featuring contributions by some Real Science Radio favorites!

* A Natural Selection: Fred Williams and Doug McBurney are joined on the air by author and researcher Tom Rogers, president of the Atomic Biology Institute to discuss his latest efforts to replace Darwinism with the Biblical and historical truth of how we are made and cared for by a super intelligent and loving God. * Honesty from Harvard: Harvard evolutionist Richard Lewontin admitted: "Our willingness to accept scientific claims that are against common sense is the key to an understanding of the real struggle between science and the supernatural. We take the side of science in spite of the patent absurdity of some of its constructs...in spite of the tolerance of the scientific community for unsubstantiated just-so stories, because we have a prior commitment, a commitment to materialism."  Anti-God and Anti-science. “in the last chapter of Biology as Ideology, Lewontin argued that "while traditional Darwin has portrayed the organism as a passive recipient of environmental influences, a correct understanding should emphasize the organism as an active constructor of its own environment." * Rom 1:25: “Who changed the truth of God into a lie, and worshipped and served the creature more than the Creator, who is blessed for ever. Amen. * Theistic Evolution: A Scientific, Philosophical and Theological Critique – Get the book featuring contributions by some Real Science Radio favorites!

Welcome to another episode of the Oncology Brothers podcast! In this episode, Drs. Rahul and Rohit Gosain are joined by Dr. Cathy Eng, a renowned GI medical oncologist from the Vanderbilt Ingram Cancer Center, to discuss the most impactful updates from the ASCO 2025 annual meeting, specifically focusing on gastrointestinal (GI) malignancies. Join us as we dive into five pivotal abstracts that are set to change the landscape of GI cancer treatment: 1.⁠ ⁠DYNAMIC III: Discover how ctDNA-guided adjuvant chemotherapy in stage 3 colon cancer did not improve outcomes, highlighting questionable role of escalating approach with ctDNA positivity. 2.⁠ ⁠ATOMIC: Learn about the addition of atezolizumab to FOLFIRI in MSI-H disease stage 3 colon cancer, which improved disease-free survival with a hazard ratio of 0.50. 3.⁠ ⁠BREAKWATER: Explore how the combination of encorafenib, cetuximab, and FOLFOX has established a new standard of care for BRAF V600E mutant metastatic colorectal cancer, doubling overall survival from 15 months to 30.3 months. 4.⁠ ⁠MATTERHORN: Understand the use of durvalumab in the perioperative and postoperative setting with the FLOT regimen for resectable gastric and GE junction adenocarcinoma, showing significant improvements in event-free survival. 5.⁠ ⁠DESTINY Gastric04: Delved into the findings that confirm TDXd as a preferred option in the second line and beyond for HER2 positive metastatic gastric cancer or GE junction adenocarcinoma. YouTube: https://youtu.be/hllyI5S2Dqg Follow us on social media: •⁠  ⁠X/Twitter: https://twitter.com/oncbrothers •⁠  ⁠Instagram: https://www.instagram.com/oncbrothers •⁠  Website: https://oncbrothers.com/ Tune in for an insightful discussion that will keep you updated on the latest advancements in GI oncology! Don't forget to subscribe for more episodes on treatment algorithms, FDA approvals, and conference highlights.

Sponsor Details:This epiosode is broght to you by NordVPN...the official VPN service of SpaceTime. Get online security at a special SpaceTime price. Details at www.nordvpn.com/stuartgaryor use the code STUARTGARY at checkout.In this episode of SpaceTime, we explore groundbreaking discoveries and significant events unfolding in our universe.Galactic Collision Course: Two Massive Galaxy Clusters Set for Round TwoAstronomers have observed a rare cosmic event as two massive galaxy clusters, previously collided, are now on a trajectory for another encounter. Located 2.8 billion light-years away, the clusters—designated PSE2G 181.06.48.47—exhibit fascinating structures and shock fronts indicative of their impending collision. We delve into the implications of this rare event and what it reveals about the dynamics of galaxy clusters and dark matter.NASA's Psyche Mission Switches to Backup SystemsNASA has been compelled to switch to a backup fuel system on its Psyche spacecraft after a drop in fuel pressure was detected in the main propulsion system. We discuss the technical challenges faced by the mission team, the significance of the asteroid Psyche, and what this means for the spacecraft's journey to explore this intriguing metallic asteroid, scheduled for arrival in 2029.Discovery of a New Atomic NucleusFor the first time in over three decades, scientists have measured the heaviest nucleus decaying through proton emission. This discovery, involving the lightest known isotope of astatine-188, sheds light on the rare form of radioactive decay and the intricate properties of exotic nuclei. We explore the experimental techniques used and the theoretical implications of this groundbreaking finding.www.spacetimewithstuartgary.com✍️ Episode ReferencesAstrophysical Journalhttps://iopscience.iop.org/journal/0004-637XNASA Psyche Missionhttps://www.nasa.gov/psycheBecome a supporter of this podcast: https://www.spreaker.com/podcast/spacetime-space-astronomy--2458531/support.00:00 This is Space Time Series 28, Episode 71 for broadcast on 13 June 202501:00 Galactic collision course: Two massive galaxy clusters set for round two12:15 NASA's Psyche mission switches to backup systems22:30 Discovery of a new atomic nucleus30:00 Science report: Unprecedented ocean warming in the South Pacific